AstraZeneca PLC (BCBA:AZN)

Argentina flag Argentina · Delayed Price · Currency is ARS
44,950
-1,600 (-3.44%)
At close: Jul 15, 2025, 5:00 PM BRT
-20.72%
Market Cap 280.70T
Revenue (ttm) 59.00T
Net Income (ttm) 8.34T
Shares Out n/a
EPS (ttm) 5,332.77
PE Ratio 33.66
Forward PE 15.81
Dividend 699.75 (1.55%)
Ex-Dividend Date Feb 21, 2025
Volume 4,634
Average Volume 617
Open 46,425
Previous Close 46,550
Day's Range 44,900 - 46,425
52-Week Range 34,800 - 58,050
Beta n/a
RSI 56.52
Earnings Date Jul 29, 2025

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 94,300
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol AZN
Full Company Profile

Financial Performance

In 2024, AstraZeneca's revenue was $54.07 billion, an increase of 18.03% compared to the previous year's $45.81 billion. Earnings were $7.04 billion, an increase of 18.14%.

Financial numbers in USD Financial Statements

News

There is no news available yet.